APA (7th ed.) Citation

JM, G., G, L., A, C., O, G., L, A., & J, V. (2023). Comment on Serés-Noriega et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45: 2412-2421. Diabetes care, 46(3), e85. https://doi.org/10.2337/dc22-2344

Chicago Style (17th ed.) Citation

JM, González-Clemente, Llauradó G, Cano A, Giménez-Palop O, Albert L, and Vendrell J. "Comment on Serés-Noriega Et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45: 2412-2421." Diabetes Care 46, no. 3 (2023): e85. https://doi.org/10.2337/dc22-2344.

MLA (9th ed.) Citation

JM, González-Clemente, et al. "Comment on Serés-Noriega Et al. Use of the Steno T1 Risk Engine Identifies Preclinical Atherosclerosis Better Than Use of ESC/EASD-2019 in Adult Subjects With Type 1 Diabetes at High Risk. Diabetes Care 2022;45: 2412-2421." Diabetes Care, vol. 46, no. 3, 2023, p. e85, https://doi.org/10.2337/dc22-2344.